Health.Global
Medical Care Facilities · HCG
Mid CapHealthcareHigh Growth
Meghraj Arvindrao Gore
Chief Executive Officer · Pragmatic
Company DNA
Performance-Driven
About
Health.Global is a Mid Cap company in the Healthcare sector, listed on NSE as HCG. With a market cap of ₹8K Cr and revenue of ₹2K Cr, it is currently in the High Growth phase. Known for its Performance-Driven culture and Fast-Follower approach to innovation, the company operates at a Steady-Marathon pace. Operates in a high-stakes healthcare delivery model requiring strict standard operating procedures and performance metrics. Its strategic mandate: Rapid infrastructure scaling requires a focus on medical outcomes and patient trust to maintain premium positioning in competitive markets.
FAQ
What kind of company is Health.Global?
Health.Global is a Mid Cap Healthcare company (HCG) in the High Growth phase with a market cap of ₹8K Cr. It is classified as Performance-Driven in culture.
What is Health.Global's culture and work environment like?
Health.Global has a Performance-Driven culture with Fast-Follower innovation DNA and a Steady-Marathon pace of execution. Employee brand: Learning Ground. Customer relationship style: Premium-Niche. Operates in a high-stakes healthcare delivery model requiring strict standard operating procedures and performance metrics.
Who leads Health.Global?
Health.Global is led by Meghraj Arvindrao Gore (Chief Executive Officer), a Pragmatic leader with 28 years of experience.
What are Health.Global's financials?
Health.Global reported revenue of ₹2K Cr in FY25 with a 5-year revenue CAGR of 16.7%. Operating margin: 8.5%. Market cap: ₹8K Cr.
Culture & Strategy
CulturePerformance-Driven
InnovationFast-Follower
PaceSteady-Marathon
PurposeMission-First
CustomerPremium-Niche
EmployeeLearning Ground
BrandTechnical-Expert
LifecycleHigh Growth
Operates in a high-stakes healthcare delivery model requiring strict standard operating procedures and performance metrics.
Mandate
Rapid infrastructure scaling requires a focus on medical outcomes and patient trust to maintain premium positioning in competitive markets.
Rapid infrastructure scaling requires a focus on medical outcomes and patient trust to maintain premium positioning in competitive markets.
Financials
Revenue FY25₹2K Cr
PAT FY25₹44 Cr
Rev CAGR 5Y16.7%
OPM8.5%
NPM2%
ROE4.8%
ROCE7.5%
P/E415.1
Fwd P/E58.1
P/B8.3
D/E177.9
Mkt Cap₹8K Cr
Promoter70.5%
Institutional16.9%
Similar Culture
Could You Lead Health.Global?
Take the Genome Benchmark →